http://phasebio.com
PhaseBio Pharmaceuticals, Inc. Company Intro
Industry
Healthcare
PhaseBio Pharmaceuticals, Inc. Headquaters
1 Great Valley Parkway
Malvern,19355
United States
PhaseBio Pharmaceuticals, Inc. Share price
17 May 2023 13:43 GMT
$0
0.0 (0 %)
PhaseBio Pharmaceuticals, Inc. Market cap
$
WMC RANKING
2023
PhaseBio Pharmaceuticals, Inc. # 264
BiotechnologyLatest PhaseBio Pharmaceuticals, Inc. News
18 Sep 2023
Achondroplasia Market will Explore Robust Size & Growth ...
... Pharma, Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc., SiSaf, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, LG Chem, Ferring B.V., JCR Pharmaceuticals Co.,...
19 Sep 2023
Global Cardiovascular Drugs Market Size and Forecast ...
... Ltd., Phasebio Pharmaceuticals, Ablative Solutions, Mylan Specialty, Curemark, and Takeda Pharmaceutical Co. The growth of the Global Cardiovascular Drugs...
18 Sep 2023
Achondroplasia Market will Explore Robust Size & Growth ...
... Pharma, Inc., Pfizer Inc., PhaseBio Pharmaceuticals, Inc., SiSaf, Novo Nordisk A/S, F. Hoffmann-La Roche Ltd, LG Chem, Ferring B.V., JCR Pharmaceuticals Co.,...
WMC Market Score
WMC Market to Revenue Score
PhaseBio Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| PhaseBio Pharmaceuticals, Inc. | USD | $0 | $96,215 | $-111,018 | $ | 264 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $804,390B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $878,880B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $144,340B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total PhaseBio Pharmaceuticals, Inc. Social Followers vs Top 4 Industry Competitors
PhaseBio Pharmaceuticals, Inc. Post vs Top 4 Industry Competitors
PhaseBio Pharmaceuticals, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
PhaseBio Pharmaceuticals, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
PhaseBio Pharmaceuticals, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| PhaseBio Pharmaceuticals, Inc. | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 28 | 0 | 0 | 29.94 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 40 | 0 | 0 | 36.32 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 32 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 45.31 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
